Skip to main content

Table 2 Hormone and biomarker levels of TART patients before and after treatment

From: Sonographic features of the testicular adrenal rests tumors in patients with congenital adrenal hyperplasia: a single-center experience and literature review

Patient No.

Treatment

LH (IU/L)

FSH (IU/L)

PRL (ng/mL)

P (ng/mL)

T (ng/mL)

E (pg/mL)

ACTH(pg/ml)

17-OHP(ng/ml)

HCG

AFP

Pre

Post

Pre

Post

Pre

Post

Pre

Post

Pre

Post

Pre

Post

Pre

Post

Pre

Post

  

1

Dexamethasone

5.1

8.21

2.96

4.44

12.6

/

10.94

33.06

553.4

7.17

20

38

282

/

29.5

/

<5

2.4

2

Hydrocortisone

20.1

/

0.5

/

/

/

20

/

18.7

/

99.48

/

157

/

299.9

/

<0.5

1.9

3

Dexamethasone

14.34

12.79

17.29

24.95

/

/

5.44

2.85

1.71

2.46

19

12

539

41.2

84.5

3.92

/

/

4

Hydrocortisone

6.41

0

6.42

0

7.24

35

/

/

25.51

3.66

38

240.6

32.4

14.6

40.1

19.68

0

1.7

5

Hydrocortisone

4.44

8.59

8.21

10.45

/

/

33.06

5.27

2.17

6.23

38

27

410

516

DS:

184.6

DS:

200.6

/

/

6

Hydrocortisone

2.66

11.38

6.3

6.22

/

/

15.3

6.68

5.54

6.29

27

23

291

798

DS:

89.3

DS:

74.4

/

/

7

Prednisone

0.96

1.88

5.21

5.49

/

/

2.7

4.88

3.59

4.36

5

35

254

213

DS:

29.0

DS:

36.1

<0.1

1.7

8

Hydrocortisone

0.18

1.10

0.76

0.21

/

/

39

0.39

2.07

< 0.1

18

< 5

373

170

64.31

4.47

0.8

1.1

  1. Abbreviations: LH luteinizing hormone, FSH follicle-stimulating hormone, PRL prolactin, P progesterone, T testosterone, E estrogen, ACTH adrenocorticotropic hormone, 17-OHP 17 hydroxyprogesterone, HCG human chorionic gonadotropin, AFP alpha fetoprotein, Pre pre-treatment, Post post-treatment, DS dehydroepiandrosterone-s